b Tested in sodium chloride 0.9%.
c Tested in Ringer’s injection, lactated.
d Tested in bacteriostatic sodium chloride 0.9% preserved with benzyl alcohol 0.9%.
e Imipenem component. Imipenem in a 2:2:1 fixed-ratio concentration with cilastatin and relebactam.
f Test performed using the formulation WITH edetate disodium.
g Lyophilized formulation tested.
h Refer to Appendix for the composition of parenteral nutrition solutions. TNA indicates a 3-in-1 admixture, and TPN indicates a 2-in-1 admixture.
i Ceftolozane component. Ceftolozane in a 2:1 fixed-ratio concentration with tazobactam.
j Injected via Y-site into an administration set running azithromycin.
k Test performed using the formulation WITHOUT edetate disodium.
l Ampicillin component. Ampicillin in a 2:1 fixed-ratio concentration with sulbactam.
m Piperacillin component. Piperacillin in an 8:1 fixed-ratio concentration with tazobactam.
n Not specified whether concentration refers to single component or combined components.
o Meropenem component. Meropenem in a 1:1 fixed-ratio concentration with vaborbactam.
p Tested in both dextrose 5% and sodium chloride 0.9%.
q Sulbactam component. Sulbactam in a 1:1 fixed-ratio concentration with durlobactam.